Develops cost-effective medical sensors using semiconductor and signal processing technology to deliver high-quality, actionable data to clinicians. These devices enable early intervention for vulnerable populations by improving diagnostic accuracy and reducing healthcare costs.
Funding
$14.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Vulnerable populations often face delayed intervention for debilitating or life-threatening events due to the high cost and limited accessibility of medical-quality sensors required for early diagnosis. Current clinical workflows lack economically feasible solutions for widespread deployment of diagnostic tools.
Solution
Trivirum develops cost-effective medical devices leveraging semiconductor and signal processing technology to provide clinicians with high-quality, actionable data. Their solutions aim to improve health outcomes for patients worldwide by enabling early intervention and reducing healthcare costs. By focusing on superior test quality and affordability, Trivirum strives to create economically viable clinical workflows suitable for broad implementation, particularly for vulnerable populations at risk.
Target Audience
The primary target audience includes clinicians and healthcare providers seeking affordable and effective diagnostic tools for early intervention, as well as health plans aiming to reduce costs.
Features
- Medical-quality sensors utilizing semiconductor technology
- Signal processing technology for actionable data delivery
- Cost-effective design for widespread deployment